Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Surgery for hyperthyroidism in Down syndrome: case report.

Mustafa Sahin1, Neslihan Bascil Tutuncu, Mehmet Kanbay

  • 1Baskent University, Department of Endocrinology and Metabolism, 5th Street, Bahcelievler, Ankara/Turkey. drsahinmustafa@yahoo.com

The Mount Sinai Journal of Medicine, New York
|September 30, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical outcomes of glucagon-like peptide-1 receptor agonist therapy in kidney transplant recipients: a systematic review and meta-analysis.

Clinical kidney journal·2026
Same author

Abdominal Waist Circumference and Subcutaneous Adipose Tissue Thickness Predicts Development of Post-Transplant Diabetes Mellitus.

Research square·2026
Same author

Prognostic Stratification in Primary Glomerulonephritis: Integrating Histology, Biomarkers, and Risk Prediction Models.

Life (Basel, Switzerland)·2026
Same author

Clinical Management of Weight Regain and Cardiometabolic Consequences After Discontinuation of GLP-1 Receptor Agonists.

Diabetes, obesity & metabolism·2026
Same author

Safety of GLP-1 and Dual GLP-1/GIP Receptor Agonists in Preconception, Pregnancy, and Lactation: A Systematic Review of Maternal, Fetal, and Neonatal Outcomes.

Diabetes, obesity & metabolism·2026
Same author

When KDIGO Meets Frailty: Rethinking Chronic Kidney Disease Targets in Adults Aged 80 Years and Older.

American journal of nephrology·2026
Same journal

Farewell message from Penny A. Asbell, MD, FACS, MBA, Editor-in-Chief of the Mount Sinai Journal of Medicine.

The Mount Sinai journal of medicine, New York·2012
Same journal

Minority undergraduate programs intended to increase participation in biomedical careers.

The Mount Sinai journal of medicine, New York·2012
Same journal

Future of electronic health records: implications for decision support.

The Mount Sinai journal of medicine, New York·2012
Same journal

AA amyloidosis: Mount Sinai experience, 1997-2012.

The Mount Sinai journal of medicine, New York·2012
Same journal

Amyloid neuropathies.

The Mount Sinai journal of medicine, New York·2012
Same journal

Should your family history of coronary heart disease scare you?

The Mount Sinai journal of medicine, New York·2012
See all related articles

Hyperthyroidism is rare but underestimated in Down syndrome (DS). This case highlights recurrence and treatment challenges, suggesting surgery

Area of Science:

  • Endocrinology
  • Genetics
  • Internal Medicine

Background:

  • Thyroid disorders are prevalent in Down syndrome (DS).
  • Hyperthyroidism is less common than hypothyroidism in DS but often overlooked.
  • Adult patients with DS require careful management of thyroid conditions.

Observation:

  • A case of an adult male with Down syndrome presenting with recurrent hyperthyroidism.
  • The patient experienced leukopenia and elevated liver enzymes after initial antithyroid therapy.
  • Subtotal thyroidectomy was performed following preparation with inorganic iodine and prednisone.

Findings:

  • Post-thyroidectomy, the patient developed hypothyroidism requiring thyroid replacement therapy.
  • Literature review indicates undefined roles for surgical intervention in hyperthyroid DS patients.

Related Experiment Videos

  • Management of hyperthyroidism in DS presents unique challenges, including potential complications and treatment resistance.

    • Implications:

    • This case underscores the importance of vigilant monitoring for hyperthyroidism in individuals with DS.
    • The optimal treatment strategy for hyperthyroidism in DS remains to be established.
    • Further research is needed to define the role of surgery and other modalities in managing hyperthyroidism in this population.